25I-NBMD Stats & Data

25I-NBMD is a highly-potent benzylated phenethylamine in the NBMD sub-series (N-benzodioxolylmethyl), with microgram-level active doses; sub-milligram accuracy is essential. Use volumetric dosing and avoid ‘eyeballing’; consumer 0.001 g scales are not reliable below ~10–20 mg, so dilute a known mass into a measured volume and dose by mL. NBxx blotters are often bitter and can cause local numbing; the harm-reduction maxim “if it’s bitter, it’s a spitter” reflects that LSD blotters are usually not notably bitter or numbing. Because NBxx compounds (including NBOMe) are frequently mis-sold as LSD, test your blotter: an Ehrlich-type LSD field test (or NIK LSD pouch) will turn purple for LSD but shows no reaction for NBOMe-like phenethylamines; additionally, LSD spots glow under UV whereas NBOMe spots typically do not. Insufflation of NBxx is strongly discouraged: several NBOMe medical emergencies and fatalities followed nasal dosing; apply the same caution to NBMD. Redosing can unpredictably extend duration and body-load; avoid multiple doses in one session. Mis-weighed microgram doses are the primary cause of severe NBxx incidents; start with an allergy microdose (e.g., ≤100–200 µg of a well-mixed volumetric solution), wait a full 90 minutes, then proceed cautiously. Because stimulant-like vasoconstriction and tachycardia can occur, avoid combining with stimulants or hot environments; maintain light, periodic hydration and cooling. If chest pain, extreme agitation, confusion, or seizure occurs, seek emergency help; benzodiazepines are typically used medically to control agitation and seizures with serotonergic psychedelics, but do not self-medicate to push doses higher.